Breast Cancer Trial, Recruiting NCT06833255 Sponsor: Roswell Park Cancer Institute Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06833255
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who can speak and read English
  • People who are 18 years of age or older
  • People who live in the Western New York area
  • People who have been diagnosed with breast cancer, at any stage
  • People who have finished their main breast cancer treatments (such as chemotherapy, radiation, or surgery, not including breast reconstruction)
  • People in the mentor role must have finished their main treatments at least one year ago
  • People in the mentee role must have finished their main treatments less than one year ago
  • People who are still on hormonal therapy (such as tamoxifen) or waiting for breast reconstruction surgery are still considered to have completed main treatment and may be eligible
  • While any breast cancer survivor may be considered, the trial will give priority to people who have recently moved into life after treatment, people who did not have access to support during that transition, and people who identify as African American

Who may not be able to join:

  • People who are currently receiving chemotherapy, other systemic cancer therapies, or radiation treatment (note: ongoing hormonal therapy does not count as an excluding treatment)
  • People who are unable or unwilling to complete the study assessments in English
  • People who are currently pregnant or breastfeeding
  • People who are unwilling or unable to follow the study's requirements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Roswell Park Cancer Institute
Registry
ClinicalTrials.gov
Start date
21 April 2025
Est. completion
30 March 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Community-clinical linkages; Facilitators to implementation; Barriers to implementation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov